主页
新闻
翻译
项目
论坛
说明
成员
登录
注册
. .
•个人资料
ervintoth
•所有译文
▪▪索译列单
•
收藏列单
•项目目录
•收件夹
▪å…è´¹è¯è¨€äº¤æµ
•English
•Türkçe
•Français
•Español
•Italiano
•Português brasileiro
•Deutsch
•Română
•عربي
•Русский
•Svenska
•Ελληνικά
•Български
•עברית
•Shqip
•Srpski
•Nederlands
•Dansk
•Português
•Polski
▪▪汉语(简体)
•Lietuvių
•Norsk
•فارسی
•Suomi
•Hrvatski
•日本語
•Català
•Esperanto
•한국어
•Українська
•Føroyskt
•नेपाली
•Kiswahili
所有译文
搜索
索译列单 - ervintoth
搜索
源语言
目的语言
约有2项,以下是第1 - 2项
1
384
源语言
ASSESSMENT OF SMALL BOWEL SAFETY OF LUMIRACOXIB 100 MG OD
Of 152 randomized subjects, 139 completed the study with valid VCEs. Compared with placebo, an increased number of subjects on naproxen plus omeprazole had small bowel mucosal breaks , with increased permeability and raised faecal calprotectin . .There was no increase in permeability. As assessed by three different measures, acute small bowel injury on lumiracoxib treatment is less frequent than with naproxen plus omeprazole and similar to placebo.
经手译文
Uppskattning av lumiracoxibs 100 mg od tunntarmssäkerhet
1